Moderna Shares Traded Higher Tuesday Following An Upgrade From Oppenheimer: What Investors Need To Know

  • 5 months ago
Oppenheimer analyst Hartaj Singh upgraded Moderna from Perform to Outperform on Tuesday and announced a price target of $142.